# EDGAR Filing Document

**Accession Number:** 0001505497
**File Stem:** 0000000000-23-001435
**Filing Date:** 2023-2
**Character Count:** 2519
**Document Hash:** 24fcb701d248d2b0a7d80e9441d1b779
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-23-001435.hdr.sgml**: 20230315

**ACCESSION NUMBER**: 0000000000-23-001435

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230210

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BioRestorative Therapies, Inc.
- **CENTRAL INDEX KEY:** 0001505497
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **IRS NUMBER:** 911835664
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD

**BUSINESS ADDRESS:**
- **STREET 1:** 40 MARCUS DRIVE
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747
- **BUSINESS PHONE:** (631) 760-8100

**MAIL ADDRESS:**
- **STREET 1:** 40 MARCUS DRIVE
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Stem Cell Assurance, Inc.
- **DATE OF NAME CHANGE:** 20101110

## Text-Extract

```

United States securities and exchange commission logo

                           February 10, 2023

       Lance Alstodt
       President and Chief Executive Officer
       BioRestorative Therapies, Inc.
       40 Marcus Drive, Suite One
       Melville, New York 11747

                                                        Re: BioRestorative
Therapies, Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed February 7,
2023
                                                            File No. 333-269631

       Dear Lance Alstodt:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Jane
Park at 202-551-7439 with any questions.

                           Sincerely,

                           Division of Corporation Finance

                           Office of Industrial Applications and

                           Services
       cc:                                              Fred Skolnik, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._